Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

South Korea · Delayed Price · Currency is KRW

7,630.00

-1,010.00 (-11.69%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medicines	411.91B	349.71B	286.81B	282.30B	290.18B
Medicines Growth	17.78%	21.93%	1.60%	-2.71%	6.31%
Food	628.43B	567.36B	563.72B	542.93B	474.14B
Food Growth	10.76%	0.65%	3.83%	14.51%	-0.38%
MRO	610.30B	605.38B	589.81B	523.26B	492.67B
MRO Growth	0.81%	2.64%	12.72%	6.21%	-1.63%
Other	17.72B	17.49B	19.88B	13.43B	15.39B
Other Growth	1.33%	-12.00%	48.00%	-12.76%	-2.38%
Consolidation Adjustment	-27.65B	-25.48B	-28.67B	-23.74B	-28.61B
Total	1.64T	1.51T	1.43T	1.34T	1.24T
Total Growth	8.34%	5.79%	6.98%	7.59%	0.45%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Korea	1.64T	1.51T	1.42T	1.33T	1.24T
Korea Growth	8.73%	6.13%	7.14%	7.37%	0.85%
Asia	19.61B	29.26B	37.99B	34.46B	36.00B
Asia Growth	-32.98%	-22.98%	10.26%	-4.29%	-9.12%
Europe	7.59B	1.22B	-	-	-
Europe Growth	522.64%	-	-	-	-
Consolidation Adjustment	-27.65B	-25.48B	-28.67B	-23.74B	-28.61B
Total	1.64T	1.51T	1.43T	1.34T	1.24T
Total Growth	8.34%	5.79%	6.98%	7.59%	0.45%

Source: S&P Global Market Intelligence.